Jaguar Health (JAGX) Shares Outstanding (Weighted Average) (2014 - 2026)
Jaguar Health (JAGX) reported Shares Outstanding (Weighted Average) of $515788.0 for Q1 2026, up 2780.85% year-over-year from $17904.0 in Q1 2025, and up 386.81% quarter-over-quarter from $105953.0 in Q4 2025.
Jaguar Health (JAGX) Shares Outstanding (Weighted Average) (2014 - 2026) Analysis & Trends
Jaguar Health (JAGX) has 13 years of Shares Outstanding (Weighted Average) data on file, last reported at $515788.0 in Q1 2026.
- Shares Outstanding (Weighted Average) for Q1 2026 came in at $515788.0, up 2780.85% year-over-year; the trailing twelve-month figure through Mar 2026 was $515788.0 (up 2780.85% YoY), and the FY2025 annual result was $2.3 million, up 691.9% from the prior year.
- Shares Outstanding (Weighted Average) climbed to $515788.0 in Q1 2026 per JAGX's latest filing, from $105953.0 in the prior quarter.
- Over five years, Shares Outstanding (Weighted Average) peaked at $5.1 million in Q1 2023 and troughed at $5.0 in Q4 2022.
- A 5-year average of $1.0 million and a median of $374805.0 in 2024 frame the typical range for Shares Outstanding (Weighted Average).
- The sharpest annual moves came in 2022 and 2023: Shares Outstanding (Weighted Average) slumped 99.93% in 2022, then surged 161360.0% in 2023.
- A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $5.0 in 2022, then surged by 161360.0% to $8073.0 in 2023, then slumped by 98.92% to $87.0 in 2024, then jumped by 121685.06% to $105953.0 in 2025, then surged by 386.81% to $515788.0 in 2026.
- Business Quant data shows JAGX's Shares Outstanding (Weighted Average) at $515788.0 in Q1 2026, $105953.0 in Q4 2025, and $1.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | 185,491.37 Bn |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | 400.00 Bn |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | 4,489.46 Bn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 100.00 Bn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | 118.76 Bn |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | 417.01 Bn |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | 68.88 Bn |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 254.10 Mn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | 928.40 Mn |
| 10 | Jaguar Health | 1.44 Mn | -10.19 Mn | 19.11 Mn | 515,788.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 515,788.00 |
| Dec 31, 2025 | 105,953.00 |
| Sep 30, 2025 | 1.51 Mn |
| Jun 30, 2025 | 2.09 Mn |
| Mar 31, 2025 | 17,904.00 |
| Dec 31, 2024 | 87.00 |
| Sep 30, 2024 | 374,805.00 |
| Jun 30, 2024 | 3.57 Mn |
| Mar 31, 2024 | 105,895.00 |
| Dec 31, 2023 | 8,073.00 |
| Sep 30, 2023 | 345,657.00 |
| Jun 30, 2023 | 190,073.00 |
| Mar 31, 2023 | 5.11 Mn |
| Dec 31, 2022 | 5.00 |
| Sep 30, 2022 | 1.42 Mn |
| Jun 30, 2022 | 927,040.00 |
| Mar 31, 2022 | 778,512.00 |
| Dec 31, 2021 | 7,513.00 |
| Sep 30, 2021 | 44.17 Mn |
| Jun 30, 2021 | 45.04 Mn |